TOCQUEVILLE ASSET MANAGEMENT L.P. - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$98,000
-90.3%
11,500
-85.9%
0.00%
-91.7%
Q2 2015$1,008,000
-3.5%
81,500
-7.4%
0.01%0.0%
Q1 2015$1,045,000
+2.8%
88,000
-2.2%
0.01%
+9.1%
Q4 2014$1,017,000
+93.0%
90,000
+50.0%
0.01%
+83.3%
Q3 2014$527,000
-32.8%
60,000
-44.2%
0.01%
-25.0%
Q2 2014$784,000
+151.3%
107,600
+73.5%
0.01%
+100.0%
Q1 2014$312,000
+66.8%
62,000
+77.1%
0.00%
+33.3%
Q4 2013$187,000
-44.0%
35,000
-29.4%
0.00%
-40.0%
Q2 2013$334,00049,5500.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders